| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return | vs S&P 500 ⓘ |
|---|---|---|---|---|---|---|
|
MRK
Merck & Company
|
Aug 10, 2026 | BUY |
Strong Buy
-4.6% avg upside
43 analysts
|
$145.00
6.69% Upside
|
+3.8% | · |
|
NVO
Novo Nordisk
|
Aug 07, 2026 | HOLD |
Buy
+152.6% avg upside
26 analysts
|
— | -1.8% | · |
|
BMY
Bristol-Myers Squibb
|
Aug 04, 2026 | BUY |
Buy
-4.7% avg upside
42 analysts
|
$75.00
17.53% Upside
|
-3.4% | · |
|
NVS
Novartis
|
Jul 24, 2026 | BUY |
Buy
-11.5% avg upside
24 analysts
|
$170.00
12.58% Upside
|
-2.7% | · |
|
BIIB
Biogen
|
Jul 10, 2026 | HOLD |
Strong Buy
+21.0% avg upside
52 analysts
|
— | +5.4% | · |
|
CH:ALC
Alcon
|
Jul 01, 2026 | BUY |
Strong Buy
+17.9% avg upside
35 analysts
|
$68.81
13.41% Upside
|
+8.0% | · |
|
ELAN
Elanco Animal Health
|
Jun 23, 2026 | BUY |
Strong Buy
+34.8% avg upside
18 analysts
|
— | +2.1% | · |
|
GSK
GlaxoSmithKline
|
Jun 08, 2026 | BUY |
Hold
-11.7% avg upside
19 analysts
|
— | +2.8% | · |
|
ZTS
Zoetis
|
May 26, 2026 | HOLD |
Buy
+61.0% avg upside
23 analysts
|
— | -0.9% | · |
|
ABBV
AbbVie
|
May 13, 2026 | BUY |
Strong Buy
-3.6% avg upside
46 analysts
|
$250.00
0.21% Upside
|
+20.5% | · |
|
RHHBY
Roche Holding
|
Apr 06, 2026 | BUY |
Buy
+111.5% avg upside
14 analysts
|
$55.00
0.87% Upside
|
+11.5% | · |
|
UTHR
United Therapeutics
|
Mar 03, 2026 | BUY |
Buy
-13.9% avg upside
26 analysts
|
$560.00
12.05% Upside
|
+0.2% | · |
|
MRNA
Moderna
|
Jan 13, 2026 | HOLD |
Hold
+12.0% avg upside
38 analysts
|
— | +59.9% | · |
|
REGN
Regeneron
|
Jun 30, 2025 | HOLD |
Strong Buy
-2.5% avg upside
58 analysts
|
— | +19.4% | · |
|
GILD
Gilead Sciences
|
May 05, 2025 | BUY |
Strong Buy
-14.0% avg upside
66 analysts
|
$120.00
13.24% Downside
|
+33.3% | · |
|
ILMN
Illumina
|
Mar 28, 2025 | BUY |
Buy
-8.2% avg upside
31 analysts
|
$100.00
47.63% Downside
|
+47.1% | · |
|
BAX
Baxter International
|
Feb 24, 2025 | BUY |
Buy
+25.0% avg upside
23 analysts
|
$40.00
49.57% Upside
|
-40.1% | · |
|
TEVA
Teva Pharmaceutical
|
Jan 30, 2025 | BUY |
Buy
-17.7% avg upside
39 analysts
|
$20.00
45.54% Downside
|
+91.0% | · |
|
LLY
Eli Lilly & Co
|
Jan 22, 2025 | BUY |
Strong Buy
-12.1% avg upside
48 analysts
|
— | +45.3% | · |
|
VTRS
Viatris
|
Jan 06, 2025 | HOLD |
Buy
+45.1% avg upside
21 analysts
|
— | +9.0% | · |
|
AMGN
Amgen
|
Aug 20, 2024 | BUY |
Buy
-24.0% avg upside
57 analysts
|
$360.00
13.23% Downside
|
-7.5% | · |
|
SNY
Sanofi
|
Jul 26, 2024 | BUY |
Strong Buy
+68.9% avg upside
20 analysts
|
$60.00
37.22% Upside
|
+0.4% | · |
|
VRTX
Vertex Pharmaceuticals
|
Jun 17, 2024 | BUY |
Strong Buy
-12.3% avg upside
62 analysts
|
$550.00
8.82% Upside
|
-6.7% | · |
|
ITGR
Integer Holdings
|
Apr 29, 2024 | BUY |
Buy
-18.2% avg upside
16 analysts
|
$125.00
0.12% Downside
|
+10.8% | · |
|
INCY
Incyte
|
Apr 25, 2024 | BUY |
Buy
-10.5% avg upside
47 analysts
|
$70.00
41.76% Downside
|
+15.6% | · |
|
MDRX
Veradigm
|
Dec 07, 2022 | BUY |
Buy
+199.9% avg upside
22 analysts
|
$26.00
430.57% Upside
|
-31.3% | · |
|
EFX
Equifax
|
Oct 24, 2022 | BUY |
Strong Buy
+17.9% avg upside
39 analysts
|
$225.00
24.42% Upside
|
+8.9% | · |
|
LH
Labcorp Holdings
|
Sep 19, 2022 | HOLD |
Strong Buy
-14.9% avg upside
37 analysts
|
— | +7.9% | · |
|
DGX
Quest Diagnostics
|
Aug 17, 2022 | BUY |
Buy
-21.8% avg upside
34 analysts
|
$165.00
29.67% Downside
|
-2.1% | · |
|
ELV
Elevance Health
|
Feb 07, 2022 | BUY |
Strong Buy
+12.8% avg upside
33 analysts
|
$500.00
24.84% Upside
|
+7.4% | · |
|
IQV
IQVIA Holdings
|
Sep 10, 2021 | BUY |
Strong Buy
+3.3% avg upside
39 analysts
|
$290.00
22.61% Upside
|
-14.3% | · |
|
HCA
HCA Healthcare
|
Aug 02, 2021 | BUY |
Buy
+0.5% avg upside
36 analysts
|
$275.00
32.08% Downside
|
-15.0% | · |
|
BSX
Boston Scientific
|
Jun 07, 2021 | BUY |
Strong Buy
+30.8% avg upside
38 analysts
|
$50.00
3.55% Downside
|
-6.1% | · |
|
EBS
Emergent Biosolutions
|
May 05, 2021 | HOLD |
Buy
+450.1% avg upside
9 analysts
|
— | -47.1% | · |
|
BFH
Bread Financial Holdings
|
May 03, 2021 | BUY |
Buy
+26.3% avg upside
36 analysts
|
$135.00
19.02% Upside
|
-39.9% | · |
|
FISV
Fiserv
|
Jun 12, 2020 | BUY |
Buy
+71.2% avg upside
50 analysts
|
$115.00
111.38% Upside
|
+9.8% | · |
|
PRGO
Perrigo Company
|
Apr 17, 2020 | HOLD |
Buy
+426.8% avg upside
20 analysts
|
— | -18.2% | · |
|
LGND
Ligand Pharma
|
Mar 24, 2020 | HOLD |
Strong Buy
-7.0% avg upside
15 analysts
|
— | +92.9% | · |
|
MAN
ManpowerGroup
|
Oct 30, 2019 | HOLD |
Buy
+21.6% avg upside
17 analysts
|
— | -24.4% | · |
|
PINS
Pinterest
|
Aug 15, 2019 | BUY |
Strong Buy
+33.8% avg upside
47 analysts
|
$40.00
66.18% Upside
|
+8.3% | · |
|
FSLR
First Solar
|
Aug 31, 2016 | HOLD |
Strong Buy
+2.7% avg upside
50 analysts
|
— | +24.2% | · |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.